CAAS Capital Management’s Aprea Therapeutics APRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-9,204	Closed	-$906K	–	733
2020 Q4	$906K	Buy	+9,204	New	+$906K	0.01%	306
2020 Q3	–	Sell	-303	Closed	-$235K	–	276
2020 Q2	$235K	Buy	+303	New	+$235K	0.01%	166